SEPAR-ALAT Consensus Document on Antipneumoccal Vaccination in Smokers

Arch Bronconeumol. 2015 Jul;51(7):350-4. doi: 10.1016/j.arbres.2014.12.003. Epub 2015 Jan 29.
[Article in English, Spanish]

Abstract

Streptococcus pneumoniae is responsible for several clinical syndromes, such as community-acquired pneumonia, sinusitis, otitis media, and others. The most severe clinical entity caused by this bacteria is undoubtedly invasive pneumococcal disease. Certain factors are known to increase the risk of presenting invasive pneumococcal disease, the most important being smoking habit and underlying concomitant diseases. This article comprises a consensus document on antipneumococcal vaccination in smokers, drawn up by a Smoking Expert Group from the Spanish Society of Pulmonology and Thoracic Surgery and the Latin American Chest Association.

Keywords: Pneumococcal vaccination; Prevención; Prevention; Smoking; Tabaquismo; Vacunación antineumocócica.

Publication types

  • Consensus Development Conference
  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacterial Adhesion
  • Comorbidity
  • Cost-Benefit Analysis
  • Disease Susceptibility
  • Humans
  • Immunization Schedule
  • Immunocompromised Host
  • Nicotiana
  • Pneumococcal Infections / epidemiology
  • Pneumococcal Infections / prevention & control*
  • Pneumococcal Vaccines* / administration & dosage
  • Pneumococcal Vaccines* / economics
  • Respiratory System / drug effects
  • Respiratory System / immunology
  • Respiratory System / microbiology
  • Respiratory System / pathology
  • Risk Factors
  • Smoke / adverse effects
  • Smoking* / adverse effects
  • Smoking* / epidemiology
  • Spain / epidemiology
  • Tobacco Smoke Pollution / adverse effects
  • Vaccination* / economics

Substances

  • Pneumococcal Vaccines
  • Smoke
  • Tobacco Smoke Pollution